Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Technology Scientific & Technical Instruments
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
๏ปฟ

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > ๐ŸŒŸ One Wire. Endless Possibilities.๐ŸŒŸBart Hendriks like this
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(46)
•••
Comment by jopatcloon Dec 10, 2024 7:37am
53 Views
Post# 36354229

RE:๐ŸŒŸ One Wire. Endless Possibilities.๐ŸŒŸBart Hendriks like this

RE:๐ŸŒŸ One Wire. Endless Possibilities.๐ŸŒŸBart Hendriks like this
jopatclo wrote:
Photo du profil de Bart
Bart Hendriks aime ceci
One Wire. Endless Possibilities.

SavvyWire is the first and only sensor-guided solution designed specifically to optimize TAVR. From pre-procedure planning to real-time monitoring, it’s all about delivering predictable and efficient outcomes.

Imagine the possibilities when one wire does it all! Explore how SavvyWire is redefining TAVI procedures. https://lnkd.in/ePzr5YsP

SavvyWire TAVR InnovationInHealth Cardiology


Interesting see on  Angiopro GmbH ! Fokus Kathetergesttzte Herzklappentherapie happening yesterday and today in Berlin!
 We are at the 3mensio Structural Heart Workshop in Berlin!

We’re excited to be holding a 3mensio Structural Heart Workshop at the DGTHG Workshop Erworbene Herzklappenerkrankungen - Fokus Kathetergesttzte Herzklappentherapie happening yesterday and today in Berlin! 

This workshop showcases the latest advancements in structural heart imaging and demonstrates how 3mensio supports precise procedural planning for improved outcomes in heart valve therapies.

It’s a fantastic opportunity to connect, learn, and contribute to the future of structural heart care. 

If you’re here, come say hello—we’d love to see you!

Angiopro 3mensio StructuralHeart HeartValveTherapy PieMedicalImaging InnovationInHealth BerlinWorkshop TAVI Mitral Tricuspid

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities